Last edition
News about
Merck Showcases Cutting-Edge Pharma and Electronic Materials Production to Robert Habeck
Merck has recently welcomed Robert Habeck, the German Federal Minister for Economic Affairs and Climate Action, at its headquarters in Darmstadt.
Nestle India and Dr. Reddys to Bring Nutraceutical Brands to Consumers in India
Nestlé India Ltd. has signed a definitive agreement with Dr. Reddy’s Laboratories Ltd. to form a joint venture to bring innovative nutraceutical brands to consumers in India and other agreed territories.
Glenmark Gets ANDA Approval for Acetaminophen and Ibuprofen Tablets
Glenmark Pharmaceuticals Ltd. has received final approval from the United States Food and Drug Administration (US FDA) for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), determined by the FDA.
Sino Biological Acquires SignalChem Biotech for Expansion
Sino Biological, Inc. has successfully concluded its acquisition of Vancouver-based Canadian biotechnology company, SignalChem Biotech Inc.
Gland Pharma Receives USFDA Approval for Cetrorelix Acetate Injection
According to IQVIA, the product had US sales of approximately USD 129 million for the twelve months ending February 2024.
Union Health Secretary Explores Vaccine Collaboration at Bilthoven Biologicals in Netherlands
The focus centered on enhancing partnership and cooperation in the production of vaccines, addressing critical issues related to pandemic preparedness.
Parexel Join Hands with Palantir to Boost Clinical Data Delivery for Patients
Parexel has forged a multi-year strategic partnership with Palantir Technologies Inc. to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharmaceutical customers.
Camber Adds Aripiprazole OS to its Product Family
Camber Pharmaceuticals has expanded its product line with the addition of Aripiprazole Oral Solution, complementing the existing product family that included Aripiprazole Tablets.
Hyundai Bioscience's Antiviral for Dengue Fever to Enter Clinical Trials in Brazil
Hyundai Bioscience announced that after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in Brazil, which has the highest number of dengue cases and deaths in the world.
BM Birla Heart Hospital Organizes Session on Knowledge Sharing and Best Practices Workshop on IVUS
BM Birla Heart Hospital organized a session on knowledge sharing and best practices workshop on Intravascular Ultrasound (IVUS) by a renowned medical practitioner of international fame to provide improved patient outcomes through new technologies and deliver precise and accurate treatment to patients suffering from complex coronary diseases.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy